Banco Bilbao Vizcaya Argentaria, S.A. Moderna, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $9.35 Billion
- Q4 2024
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 337,230 shares of MRNA stock, worth $11.4 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
337,230
Previous 169,328
99.16%
Holding current value
$11.4 Million
Previous $11.3 Million
23.91%
% of portfolio
0.15%
Previous 0.13%
Shares
18 transactions
Others Institutions Holding MRNA
# of Institutions
923Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.37 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.32 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$867 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$596 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$248 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...